BNP Paribas Downgrades Organon to Neutral, Raises Price Target to $14
Benzinga Newsdesk 6 months ago
NewsDowngradesPrice TargetAnalyst Ratings
BNP Paribas analyst Navann Ty downgrades Organon (NYSE:OGN) from Outperform to Neutral and raises the price target from $12 to $14.
BNP Paribas analyst Navann Ty downgrades Organon (NYSE:OGN) from Outperform to Neutral and raises the price target from $12 to $14.